Chronic Hepatitis

Top Story

Albumin predicts cirrhosis improvement after SVR with DAAs

April 20, 2018
Meeting NewsVideo

Zepatier for 8 weeks safe, effective for HCV genotypes 1b, 4

April 20, 2018
PARIS — In this exclusive interview from the International Liver Congress 2018, Christophe Hezode, MD, discusses positive study results from two presentations on…
Meeting News

DAA therapy effective in patients with HCV and advanced cirrhosis

April 16, 2018
PARIS — Direct-acting antiviral therapy effectively treated hepatitis C virus in patients with high MELD scores, producing a high rate of sustained viroloic…
Meeting News

8-weeks of Zepatier may effectively treat HCV genotype 4

April 14, 2018
PARIS — In patients with hepatitis C virus genotype 4, 8 weeks of Zepatier showed effective treatment of the virus, according to a presentation at the…
More Headlines »